Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,148 | -34,567 | -17,885 | -96,226 | -78,886 |
| Depreciation Amortization | 6,792 | 4,602 | 2,436 | 10,018 | 7,150 |
| Income taxes - deferred | N/A | N/A | N/A | -498 | -376 |
| Accounts payable and accrued liabilities | 342 | -65 | 670 | -1,100 | -66 |
| Other Working Capital | -8,243 | -4,011 | 491 | -554 | 332 |
| Other Operating Activity | 4,780 | 4,136 | 1,210 | 24,979 | 22,498 |
| Operating Cash Flow | $-46,477 | $-29,905 | $-13,078 | $-63,381 | $-49,348 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -74,302 | -4,989 | -17,355 | -94,770 | 52,947 |
| PPE Investments | -3,502 | -3,089 | -2,104 | -12,690 | -11,037 |
| Purchase Of Investment | N/A | N/A | N/A | -723 | -723 |
| Sale Of Investment | 87,100 | N/A | N/A | 165,284 | N/A |
| Other Investing Activity | -3 | -3 | 0 | 0 | 0 |
| Investing Cash Flow | $9,293 | $-8,081 | $-19,459 | $57,101 | $41,187 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -477 | -335 |
| Common Stock Issued | 39,221 | 39,221 | 39,221 | 57 | 57 |
| Common Stock Repurchased | -501 | -501 | N/A | -228 | 0 |
| Other Financing Activity | -66 | -26 | -26 | -123 | -123 |
| Financing Cash Flow | $38,654 | $38,694 | $39,195 | $-771 | $-401 |
| Beginning Cash Position | 17,000 | 17,000 | 17,000 | 24,051 | 24,051 |
| End Cash Position | 18,470 | 17,708 | 23,658 | 17,000 | 15,489 |
| Net Cash Flow | $1,470 | $708 | $6,658 | $-7,051 | $-8,562 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,477 | -29,905 | -13,078 | -63,381 | -49,348 |
| Capital Expenditure | -3,502 | -3,089 | -2,104 | -13,102 | -11,057 |
| Free Cash Flow | -49,979 | -32,994 | -15,182 | -76,483 | -60,405 |